Trial NCT01121588

View at ClinicalTrials.gov 
Org. Study IDs: A8081013
Secondary IDs: 2010-022978-14 PROFILE 1013

Last trial update was posted on 2023-11-09

MeSH Interventions

Crizotinib

MeSH Conditions

Lymphoma Neoplasms

Other Conditions

Neoplasms Malignant

Stopping Reasons

Termination of further treatment on the study due to the availability of commercial supply or a rollover study (NCT05160922) that will allow active subjects to continue receiving treatment.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID